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The molecular mobility of glassy and supercooled liquid states of clotrimazole is studied using broadband
dielectric spectroscopy for a wide range of temperatures and frequency. The dielectric loss data of clotrimazole
below Tg, do not show well resolved relaxation. Above Tg, dielectric loss show the structural α-relaxation
which is reformed to shoulder like shape at high frequencies due to the secondary relaxation. The relaxation
time of α-process, τα follows Vogel-Fulcher-Tammann equation. The glass transition temperature, Tg=296K
and fragility index, m=50 are obtained from the thermal behaviour of the α-process. At temperature near Tg
the dielectric loss has Kohlrausch-Williams-Watts stretch exponential parameter βKWW=0.56. The primitive
relaxation time obtained from the coupling model coincides with the experimentally observed secondary
relaxation of clotrimazole. Hence the secondary relaxation is considered to be the Johari-Goldstein (JG)
process which may be the precursor α-process. The value of exponent βKWW increases with increase of
temperature and scaled dielectric loss do not form as single master curve. The structural relaxation α-
relaxation and JG β-relaxation process and its effects in clorimazole is discussed.
I. INTRODUCTION
Many of the active pharmaceutical ingredients are
poorly water soluble and having low bioavailability. Im-
proving the solubility and bioavailability and hence re-
duce the risk of usage of large dosage to produce de-
sirable effect in patients, is one of the prime aspect of
pharmaceutical research1. Producing the drug in amor-
phous form is one of the method to improve the enhance
dissolution rate and improve bioavailability. But amor-
phous materials are metastable having greater tendency
for devitrification even it is stored below glass transition
temperature2,3. Key factor of devitrification and reduced
shelf life is the higher molecular mobility of amorphous
pharmaceutical4–6.
Broadband dielectric spectroscopy is one of the suit-
able tool to investigate dielectric properties of various
kinds of materials- liquids, glasses, polymers and even
disordered semiconductors7,8. The dielectric relaxation
of the glass and supercooled liquid states of pharmaceu-
tical drug gives information about the molecular mobility
in this state9–11. The knowledge of the molecular mobil-
ity of the amorphous pharmaceutical may useful to avoid
devitrification and increase the shelf life of the material.
One of the explanation on possible origin of devitrifica-
tion is the secondary relaxation due to the local molecu-
lar motions in the glassy states12,13. Motion of the entire
molecule is requires for the crystal nucleation. The sec-
ondary relaxation of intermolecular origin called Johari
Goldstein (JG) β-relaxation, which is a precursor of the
structural α-relaxation, is credited to the initial process
of crystallization14,15.
a)Corresponding author, Email: ggraj 7@yahoo.com
Clotrimazole is one of the most relevant active phar-
maceutical for the antifungal medication. Clotrimazole is
listed in world health organization model list of essential
medicines16. Clotrimazole is poorly water soluble with
lower bioavailability17. The clotrimazole drug is classified
as slowly crystallizing compound18,19. Structural charac-
terisation of amorphous clotrimazole with NMR, X-ray
and neutron diffraction has been studied by Benmore et
al.
20. Viscosity influence of glass forming ability of clorti-
mazole has been investigated by Bairdet al.21. However,
no investigation is reported in literature for the molec-
ular motion of amorphous clotrimazole. In the present
study and dielectric relaxation of glassy and supercooled
states of clorimazole is studied with broadband dielectric
spectroscopy.
II. MATERIALS AND METHODS
A. Materials
Clotrimazole (1-(2-Chlorophenyl)(diphenyl)methyl]-
1H-imidazole) with chemical formula C22H17ClN2
(Sigma Aldrich) in crystalline powder was used with-
out further purification. The chemical structure of
clotrimazole is shown in Fig.1.
B. Methods
1. Raman spectroscopic measurements
Raman spectroscopic measurement of crystalline and
amorphous clotrimazole has been carried out with 785
nm radiation. Raman shift of the range of 100 to
2FIG. 1. Molecular structure of clotrimazole
1800 cm−1 has been obtained. Raman spectra of crys-
talline (powder) sample are obtained at room tempera-
ture. Crystalline powder of the sample is heated above
melting temperature (428 K) and kept 10min. to en-
sure complete melting. Then the melt is quenched with
cooling rate of 15 K/min to a temperature of 173 K.
Raman spectroscopic measurements of glass and super-
cooled states clotrimazole of various temperatures is ob-
tained by heating the glass samples from 173K to 348K.
2. Broadband dielectric spectroscopy measurements
The powder sample of clotrimazole is carefully filled in
a stainless steel sample cell of 30mm diameter. Teflon
of thickness 0.2mm was used as the spacer for the elec-
trodes. The sample cell is heated a few degree above
the melting temperature (428K) and kept 15 minutes to
ensure the complete melting of the sample. Then the
sample cell is pressed well and avoided forming bubbles.
Then it is quenched with a rate of 15K/min to a tem-
perature of 173K. Alpha analyser of Novocontrol broad-
band dielectric spectrometer was used to obtain the com-
plex dielectric data for the frequency range of 10−2Hz
to 107Hz for various temperatures. Quatro cryosystem
temperature controller of nitrogen gas cryostat is set to
a temperature stability of 0.1K and used for the measure-
ments. The glass and super cooled states of the clotima-
zole is obtained by heating the quenched sample from the
temperature 173K to 368K in proper steps.
III. RESULTS AND DISCUSSION
The crystalline powder form of clotrimazole show all
characteristic peaks of clotrimazole and it is shown
in Fig.2B. Clotrimazole show characteristic peak at
1001cm−1, 1026cm−1, 1156cm−1, 1585cm−1 as in
literature22. Amorphous clotrimazole show broader
peaks as shown in Fig.2A. The vibration bands related to
the benzene rings 1001cm−1, 1026cm−1 are much more
stronger compared to other peaks. Glass and supercooled
states of the clotrimazole do not show typical change of
position of bands. The main difference of Raman spectra
of amorphous clotrimazole from the crystalline counter-
part is the broadening of the band and softening and
hardening of the modes. There is a possibility of forma-
tion of different conformers due to the change of orienta-
tion of planes of the benzene ring of the clotrimazole in
the amorphous state.
FIG. 2. Raman spectra of clotrimazole in (A) crystalline and
(B) amorphous form.
Complex dielectric data ε∗(f)=ε′(f)-iε′′(f), of glassy
and supercooled clorimazole is obtained using broadband
dielectric spectroscopy. The dielectric loss data ε′′(f) of
amorphous clotrimazole, below and above glass transi-
tion temperature (Tg) is shown in Fig.3A and Fig.3B
respectively. The ε′′(f) below Tg do not show well sepa-
rated secondary relaxations. The ε′′(f) spectra above Tg
show structural α-relaxation and shoulder like secondary
relaxation at high frequencies. Effects of dc-conductivity
are seen at low frequencies of high temperature data.
Two dielectric process with dc conductivity effects are
generally treated as following complex dielectric function
ε∗(ω)= −i
σdc
ε0ω
+
∆εα
(1 + (iωτα
HN
)αHN )βHN
+
∆ε
β
(1 + (iωτ
β
CC
)(1−αCC ))
+ ε∞ (1)
where σdc is the dc conductivity due to the translational
motion of ions. σdc contributes σdc/(ε0ω) to the dielec-
tric loss. Dielectric constant has high frequency limit
ε∞. Asymmetric function Havriliak-Negami
23 (HN) can
be used to model the primary α-process which is an ef-
fect of cooperative motion of clotrimazole molecule. This
gives the information of the about the organization of
structure of liquid leading to viscous flow. HN func-
tion characterises the α-relaxation process with dielectric
strength ∆εα, relaxation time τα
HN
and shape parame-
ters α
HN
and β
HN
. Symmetric function Cole-Cole (CC)
is generally used to model the secondary process, with
dielectric strength ∆ε
β
, relaxation time τ
β
CC
and shape
parameter αcc. The complex dielectric data of clotrima-
zole is fitted using the Eq.(1). The dielectric loss data
3(A) (B)
FIG. 3. The dielectric loss obtained for the glassy and supercooled states of clotrimazole. (A) ε′′(f) at temperatures below Tg
do not show well resolved secondary relaxation process (line is used for the guidance for eye). (B) ε′′(f) at temperatures above
Tg show the structural α-relaxation process and secondary relaxation process at high frequencies and dc conductivity due to
the translational motion of ions. The complex dielectric data are fitted with Eq.(1) and it is shown as line.
with fit curve is shown in Fig.3B and corresponding real
part of complex dielectric data is shown in Fig.4. The
FIG. 4. ε′(f) data of clotrimazole at temperature above Tg .
Samples shows a rapid decrease of dielectric strength at tem-
perature above 343K as an indication of crystallization.
relaxation peak moves towards higher frequencies with
increase of temperature as relaxation process become
faster. Even though clotrimazole is classified as slowly
crystallizing compound which shows no crystallization
during the DSC measurements, amorphous clotrimazole
crystallizes above the temperature of 343K during dielec-
tric measurements. The molecule may acquire sufficient
energy at this temperature to crystallize. Rapid decrease
of dielectric strength of structural relaxation process is
occurred above 343K as an indication of crystallization
and it is shown in Fig.4. The density of the mobile dipoles
decreases as the increase of crystallization and hence the
strength of the structural relaxation. Isotherm dielec-
tric measurement with time may give some insight to the
crystal growth of the amorphous pharmaceuticals9,15.
The shape parameters α
HN
and β
HN
of the structural
relaxation process and the αcc of the secondary relax-
ation process show interesting temperature dependants
as in Fig.5. The exponent α
HN
behaves almost tem-
FIG. 5. Temperature dependence of the shape parameters
α
HN
and β
HN
of the primary process and αcc of the secondary
relaxation. The α
HN
is weakly temperature dependent and
has a value nearly one. The β
HN
and αcc increases with
increase of temperature. It indicates that both primary and
secondary relaxation process of clotrimazole tends towards
Debye with increase of temperature.
perature independent with value nearly one, which in-
dicates Cole-Davison type behaviour of α-relaxation pro-
cess. While the values of β
HN
of the α-relaxation process,
increase with increase of temperate and its value ranges
from 0.40 to 0.65. The shape parameter αcc of the sec-
ondary relaxation show more temperature dependence
and values ranges from 0.51 to 0.78. This indicates both
the primary and secondary relaxation tending towards
the Debye dielectric relaxation with increase of tempera-
ture. The structural relaxation time τα is obtained from
4the peak maximum frequency. It can be calculated from
the parameters of HN function24.
τα = τα
HN
sin
[
α
HN
pi
2 + 2β
HN
]
−1/α
HN
sin
[
α
HN
β
HN
pi
2 + 2β
HN
]1/α
HN
(2)
The relaxation time and viscosity of the supercooled liq-
uids generally show non-Arrhenius behaviour. Thermal
activation of α-process of clotrimazole is shown in Fig.6.
The relaxation time τα follows empirical Vogel-Fulcher-
Clotrimazole
α-relaxation
β-relaxation
CM calculation
FIG. 6. Thermal activation of α-relaxation and β-relaxation
processes of clotrimazole. Primitive relaxation τ
0
(T ) calcu-
lated by coupling model is shown.
Tammann (VFT) equation25–27.
τα = τ∞exp[DT0/(T − T0)] (3)
The strength parameter D=31.1±0.9, log(τ∞)=-
19.5±0.5 and T0=181.9±2.8K is obtained. It is widely
considered that at the glass transition temperature Tg,
the structural relaxation time, τα=100s and for clotri-
mazole Tg=296±11 is obtained from VFT parameters.
Tg obtained from dielectric data is a few degree different
from Tg=303K obtained from the DSC measurement by
Bairdet al.21, but it is within the range of experimental
error. Glasses which has Arrhenius beahviour of thermal
activation for the structural relaxation are referred as
“strong” and with non-Arrhenius beahviour are termed
“fragile”. The amount of deviation of relaxation time
from Arrhenius is generally quantifies with the fragility
index obtained from the Angell plot28. The fragility
index m, can also be obtained from the VFT parameters
as
m =
dlog
10
τα
d(Tg/T )
∣∣∣∣
T=Tg
= D
T0
Tg
(
1−
T0
Tg
)
−2
log
10
e (4)
Cooling below glass transition temperate arrests the liq-
uid structure of amorphous material and the fragility in-
dex describe how rapidly the arrested liquid structure
disrupted on heating. Higher the fragility higher is the
glass forming ability and physical stability of amorphous
system. The fragility is a key factor to find the appro-
priate storage condition of particular amorphous drug.
The fragility index of clotrimazole is m=50±12, and it
can be compared with many other glass formers, 2,3-
dimethylpentane (m=50), 3-bromopentane (m=53), bu-
tyronitrile (m=47). Clotrimazole can be classified as the
intermediate glass-former drug. Almost all glass-forming
materials have non-exponential molecular relaxation pro-
cess and it is modelled with Kohlrausch-Williams-Watts
(KWW) stretched exponential function.
φ(t) = exp
[
−
(
t
τ
KWW
)β
KWW
]
(5)
The time domain function KWW do not have a analyt-
ical function in frequency domain for all values of expo-
nent βKWW . The frequency domain data of the KWW
function can be obtained by numerical calculation of one
sided Fourier transform. The scaled dielectric loss of
clotrimazole do not overlap each other to produce mas-
ter curve as shown in Fig.7. It indicates the stretched
FIG. 7. The scaled dielectric loss of clotrimazole at different
temperatures do not overlap each other to produce the master
curve. It indicates temperature dependence of βKWW and it
is shown in the inset.
exponential exponent βKWW is temperature dependent.
The exponent βKWW increases with increase of temper-
ature. Its value ranges from 0.56 to 0.72 and it is shown
in inset of Fig.7. This show that the relaxation pro-
cess tending towards Debye process with increase of tem-
perature as indicated by the shape parameters obtained
from Eq.(1). The KWW exponent βKWW=0.56 near
Tg and it is comparable with many other pharmaceuti-
cal materials Ibuprofen (0.55), Indometacin (0.59) and
other glass forming materials 4-methylheptane (0.57),
tetraphenyl tetramethyl trisiloxane (0.58), Tributylacetyl
citrate (0.57), Trimethyl pentaphenyl trisiloxane (0.57)
and Triphenyl phosphate (0.56).
5Shamblin et al. observed that materials of lower the
value of βKWW have higher crystal nucleation rate
29.
The distribution of structural relaxation time reduces
the physical and chemical stability and consequently
the shelf life of the pharmaceutical. Faster modes of
molecular motions within the distribution of relaxation
time can be responsible for the nucleation in the glassy
state, therefore the glass formers with smaller βKWW
would be more susceptible to nucleate30. But this cor-
relation is not shown by many of the glass forming
pharmaceuticals9. Bohmer et.al. suggested an empir-
ical relation m=250±30-320βKWW and it follows most
of the glass pharmaceuticals31. Clotrimazole also follows
this empirical relation. The stretching parameter βKWW
has been often considered as a measure of degree of co-
operativity and length scale or dynamic heterogeneity of
molecular mobility reflected in the structural relaxation9.
Paluch and co-workers observed that width of α-
loss peak near Tg of the van der Waals glass form-
ers strongly anticorrelates with the dielectric strength.
For large vales of ∆εα larger the βKWW
32. Clotri-
mazole has ∆εα=2.7±0.2 and βKWW=0.56±0.02 near
Tg, which also follows this anticorrelation as inter-
mediate to Indometacin(∆εα=3.8, βKWW=0.59) and
Itraconazol(∆εα=2.4, βKWW=0.50) behaviour. The
contribution of dipole-dipole interaction potential,
Vdd ∝r
−6 (r is the distance between the molecules), to
the attractive part of the intermolecular potential which
makes the resultant potential more harmonic and the dis-
persion of α-relaxation narrower.
It is really challenging to find the origin of secondary
relaxation process in glass forming materials. Sec-
ondary relaxation process may originates either from
inter-molecular or intramoleacular process. Intermolecu-
lar process with the entire motion of the molecule may
produce a secondary relaxation process called Johari-
Goldstein (JG) β-process, which is precursors of the pri-
mary structural relaxation process33,34. The JG process
is considered to be a universal process for all glass formers
and fast secondary relaxation process of intramolecular
origin are generally noted as γ-process. Coupling model
gives the correlation of α and β processes35,36. The prim-
itive relaxation of τ
0
can be obtained from the following
empirical relation.
τ
0
= (tc)
n(τα)
(1−n) (6)
where n=1-βKWW is the coupling parameter, which is
obtained from the structural α relaxation process. The
time characterizing the crossover from independent to
cooperative fluctuation tc has vale 2×10
−12s for small
glassformers. The scaled dielectric loss data with the cal-
culated primitive relaxation at temperatures 297K and
309K are shown in the Fig.8. The scaled dielectric loss
data at 309K is fitted with the Eq.(1). The individ-
ual contributions of the α-process (HN) and β-process
(CC) relaxation process are shown. The βKWW=0.61
is obtained for T=309K and primitive relaxation time
τ
0
=8.89×10−6s obtained. Since Cole-Cole function is
FIG. 8. The scaled ε′′(f) at T=309K with KWW fit (red
curve), HN function fit for α-process (blue curve) and CC
function fit for β-relaxation process (green curve). The prim-
itive relaxation time τ
0
obtained from the coupling model cor-
responds a frequency f0 and the secondary process are close
to each other showing the secondary relaxation process in
clotrimazole is Johar-Goldstein β-relaxation process. Primi-
tive relaxation frequency f0 for T=297K is also shown in the
figure.
symmetric τ
β
CC
and relaxation time from peak maxi-
mum frequency are same and it is referred as τ
β
. The
secondary relaxation time τ
β
is well within the calculated
primitive relaxation and hence the secondary relaxation
of clotrimazole may be considered as the Johar-Goldstein
β-relaxation. The primitive relaxation calculated for the
temperature T=297K with βKWW=0.56 also shown in
the Fig.8. The calculated primitive relaxation τ
0
and
secondary relaxation τcc from Eq.(1), is shown in the
Fig.6. The β-relaxation process is thermally activated
and follows Arrhenius equation.
τ
β
= τ∞exp[Eβ/kBT ] (7)
The activation energy obtained from τcc is about 139.9
kJ/mol and that from τ
0
is about 101.2 kJ/mol. The
dielectric strength of β-process, ∆εβ decreases with de-
crease of temperature. This can be explained in terms
of the decrease in number of islands of mobility with
decrease of temperature. Near the temperature Tg, β-
process is more close to α-process, with reduced dielec-
tric strength ∆εβ as compared to that at higher temper-
atures.
IV. CONCLUSION
One of the relevant pharmaceutical drug clotrimazole
melt quenched and the molecular dynamics of glassy
and supercooled states are studied using dielectric spec-
troscopy. Complex dielectric data of amorphous clotri-
6mazole has been obtained from dielectric spectroscopy
for a wide range of temperature and frequency. The di-
electric data show structural relaxation, α-process which
follows VFT equation. Glass transition temperature Tg
and fragility m, is obtained from the VFT parameters.
Clotrimazole is considered to be an intermediate fragile
glass former. The dielectric data do not show a well sep-
arated secondary relaxation. The α-process at high fre-
quencies are influenced by the secondary relaxation pro-
cess and shoulder like shape is formed. This secondary
relaxation process coincides with the coupling model pre-
dicted primitive relaxation. Hence the secondary relax-
ation process in the clotrimazole is JG β-relaxation. The
KWW stretched exponent βKWW=0.56, near glass tran-
sition temperatures. The value of βKWW increases with
increase of temperature and hence the scaled dielectric
loss do not form a single master curve.
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